ArticleBiochemistry and biophysics reports2025
Association between serum homocysteine and kidney function in hypothyroid patients: A case-control study in Northeast Iran.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: The relationship between serum homocysteine (Hcy) and kidney function in hypothyroidism is not fully understood. This case-control study investigated the association of hyperhomocysteinemia (HHcy) with kidney function tests in patients diagnosed with clinical hypothyroidism (CH). Methods: Forty-five CH cases and 45 matched controls were recruited from a referral clinic in northeast Iran. Serum Hcy was measured using ELISA technology, and Spearman's correlation coefficients were estimated to assess the association between Hcy and various kidney function parameters. Results: In CH patients, the average Hcy level was significantly higher than in those with normal thyroid function (22.63 ± 1.21 vs 12.96 ± 0.24 μmol/L, p = 0.001). Among CH patients, 82.2 % had HHcy (60 % mild, 12.2 % moderate), while only 13.3 % of controls had mild HHcy. Hcy levels were positively correlated with TSH (r = 0.528; p = 0.001), eGFR (r = - 0.418; p = 0.004), urea (r = 0.371; p = 0.012), and creatinine (r = 0.384; p = 0.009) in CH patients. Multivariate logistic regression revealed a significant relationship between Hcy and CH [OR = 2.01, 95 % CI: 1.48-2.72, p = 0.001], even after adjusting for kidney parameters. Conclusions: Serum Hcy was increased with progressive thyroid insufficiency, independent of changes in kidney function, and could be considered a potential risk factor for developing coronary heart disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.